Patents Assigned to JENIVISION INC.
  • Use of prostacyclin antagonists for treating ocular surface nociception
    Patent number: 11857537
    Abstract: The present invention relates generally to the use of compositions and methods for treating nociceptive events that occur on the ocular surface in association with dryness, injury, environmental pollutants, and infectious and non-infectious diseases. Specifically, the present invention is directed to the use of certain compounds for treating for treating ocular pain or ocular discomfort.
    Type: Grant
    Filed: March 23, 2021
    Date of Patent: January 2, 2024
    Assignee: JENIVISION INC.
    Inventors: David Frederick Woodward, Weizhen Wang
  • Formulations for hair growth
    Patent number: 11478437
    Abstract: The present invention is directed to compositions and formulations for hair growth. The non-aqueous, preservative-free formulations are useful for the growth of hair, eyebrows and eyelash in a variety of setting. Also provided herein are non-aqueous, preservative-free formulations and methods for the treatment of dry-eye and related symptoms.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: October 25, 2022
    Assignee: JENIVISION INC.
    Inventors: Weizhen Wang, David F. Woodward
  • Use of prostacyclin antagonists for treating ocular surface nociception
    Patent number: 9827225
    Abstract: The present invention relates generally to the use of compositions and methods for treating nociceptive events that occur on the ocular surface in association with dryness, injury, environmental pollutants, and infectious and non-infectious diseases. Specifically, the present invention is directed to the use of certain compounds for treating for treating ocular pain or ocular discomfort.
    Type: Grant
    Filed: January 25, 2016
    Date of Patent: November 28, 2017
    Assignee: JENIVISION INC.
    Inventors: David Frederick Woodward, Weizhen Wang
  • Quantitative peri-orbital application of ophthalmology drugs
    Patent number: 9820954
    Abstract: The present invention is directed methods of lowering intraocular pressure in a patient suffering from elevated intraocular pressure or glaucoma and treating ocular disease by administering a drug to the periorbital skin of the patient.
    Type: Grant
    Filed: August 19, 2015
    Date of Patent: November 21, 2017
    Assignee: JENIVISION INC.
    Inventors: David F. Woodward, Weizhen Wang